CSIR Technology Portal
CSIR Technology Portal

 Technology Profile

Title:

Substituted Diazenylanilines as Fluorescence Quenchers and Their Use

Value Proposition:
  • Introduces novel substituted diazenylaniline compounds as highly effective fluorescence quenchers for biosensing and imaging.
  • Provides tunable quenching properties when conjugated to nucleic acids or other probes, improving detection sensitivity.
  • Supports versatile applications in chemical and biological sciences, including cell imaging, diagnostics, and labeling.
  • Offers enhanced performance and synthetic variants over existing fluorescent quenchers.
  • Enables advanced research, medical diagnostics, and pharmaceutical tagging, overcoming limitations of traditional methods.
Summary Application:
  • The technology improves fluorescence-based detection with higher accuracy and efficiency.
  • Applicable across multiple domains, including research, diagnostics, and pharmaceuticals.
  • Scalable and easily integrable into various experimental workflows.
  • Offers opportunities for commercial use, licensing, and product development.
Advantages:
  • Higher detection accuracy and efficiency compared to conventional quenchers.
  • Broad applicability across scientific and industrial fields.
  • Flexible and compatible with diverse probes and experimental setups.
  • Potential for commercialization through licensing and product innovation.
Commercialization Status: Licensed awaiting commercialisation
Tech. Readiness Level:
CSIR-Central Drug Research Institute
CSIR-Central Drug Research Institute[CSIR-CDRI]
:  director[at]cdri[dot]res[dot]in
:91-522-2772450
:https://www.cdri.res.in
Industrial Applications: Diagnostics [Medical Devices and Diagnostics]
Patent Application(s): IN202111054081, EP4436952, US20250066866, WO2023095166